• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 7, Issue 4
  3. Authors

Online ISSN: 2515-8260

Volume7, Issue4

FORMULATION DEVELOPMENT OF MODIFIED RELEASE DOSAGE FORM OF ANTIHYPERTENSIVE DRUG

    Raosaheb S Shendge Kishor S Salunkhe Kashid Girish

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 4, Pages 2125-2133

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Changed delivery dosage structures have been created to deliver drug to the aspect of the body where it will be ingested, to streamline dosing plans, and to guarantee that centralization of drug is kept up over a fitting time interval. Drugs that are not innately dependable require various every day dosing to accomplish the ideal therapeutic impacts. Numerous day by day dosing is regularly badly designed and can bring about missed doses, made-up doses and patient rebellious with therapeutic routine. Blood levels of drugs from conventional prompt delivery dosage structures taken more than once every day following distinct timetable normally demonstrate consecutive pinnacles and troughs (valleys) related with each dose. Intended to deliver their prescription in controlled way, at a pre-decided rate, span and area in the body to accomplish and keep up optimum therapeutic blood levels of drug.
Keywords:
    drugs Propranolol hydrochloride Bulk density Matrix tablets
  • PDF (601 K)
  • XML
(2020). FORMULATION DEVELOPMENT OF MODIFIED RELEASE DOSAGE FORM OF ANTIHYPERTENSIVE DRUG. European Journal of Molecular & Clinical Medicine, 7(4), 2125-2133.
Raosaheb S Shendge; Kishor S Salunkhe; Kashid Girish. "FORMULATION DEVELOPMENT OF MODIFIED RELEASE DOSAGE FORM OF ANTIHYPERTENSIVE DRUG". European Journal of Molecular & Clinical Medicine, 7, 4, 2020, 2125-2133.
(2020). 'FORMULATION DEVELOPMENT OF MODIFIED RELEASE DOSAGE FORM OF ANTIHYPERTENSIVE DRUG', European Journal of Molecular & Clinical Medicine, 7(4), pp. 2125-2133.
FORMULATION DEVELOPMENT OF MODIFIED RELEASE DOSAGE FORM OF ANTIHYPERTENSIVE DRUG. European Journal of Molecular & Clinical Medicine, 2020; 7(4): 2125-2133.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 169
  • PDF Download: 537
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus